Agilent Technologies (A) Net Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Agilent Technologies (A) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -44.88% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -31.58% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -40.43% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 29.57% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 0.45% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 27.19% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -35.32% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 50.05% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 58.68% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -31.58% |
| Apr 30, 2026 | 41.14% |
| Jan 31, 2026 | -31.40% |
| Oct 31, 2025 | 343.10% |
| Jul 31, 2025 | 34.46% |
| Apr 30, 2025 | -28.20% |
| Jan 31, 2025 | 34.34% |
| Oct 31, 2024 | -113.44% |
| Jul 31, 2024 | 27.62% |
| Apr 30, 2024 | -49.09% |
| Jan 31, 2024 | 48.12% |
| Oct 31, 2023 | 50.30% |
| Jul 31, 2023 | 77.50% |
| Apr 30, 2023 | -38.62% |
| Jan 31, 2023 | 46.26% |
| Oct 31, 2022 | 80.12% |
| Jul 31, 2022 | 34.67% |
| Apr 30, 2022 | -6.87% |
| Jan 31, 2022 | -22.97% |
| Oct 31, 2021 | -22.99% |